FDA Import Refusal SCS-2830007-9/11/1 — RLC Labs Inc.
The FDA refused shipment SCS-2830007-9/11/1 from RLC Labs Inc. (United States) on November 19, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,179,223,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- November 19, 2020
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,179,223,75